These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12901586)

  • 1. Melioidosis vaccines.
    Warawa J; Woods DE
    Expert Rev Vaccines; 2002 Dec; 1(4):477-82. PubMed ID: 12901586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei.
    Wiersinga WJ; van der Poll T; White NJ; Day NP; Peacock SJ
    Nat Rev Microbiol; 2006 Apr; 4(4):272-82. PubMed ID: 16541135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward development of vaccines against melioidosis: A review.
    Sarkar-Tyson M; Titball RW
    Clin Ther; 2010 Aug; 32(8):1437-45. PubMed ID: 20728758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.
    Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD
    Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.
    Su YC; Wan KL; Mohamed R; Nathan S
    Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of and immunity to melioidosis.
    Brett PJ; Woods DE
    Acta Trop; 2000 Feb; 74(2-3):201-10. PubMed ID: 10674650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkholderia pseudomallei Δ
    Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
    Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle.
    Breitbach K; Köhler J; Steinmetz I
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S89-94. PubMed ID: 19121696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to Burkholderia pseudomallei induces cell-mediated immunity in healthy individuals.
    Govan B; Ketheesan N
    Clin Microbiol Infect; 2004 Jun; 10(6):585-7. PubMed ID: 15191392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes.
    Peacock SJ; Limmathurotsakul D; Lubell Y; Koh GC; White LJ; Day NP; Titball RW
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1488. PubMed ID: 22303489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
    Titball RW; Burtnick MN; Bancroft GJ; Brett P
    Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice.
    Sangdee K; Waropastrakul S; Wongratanachewin S; Homchampa P
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1190-6. PubMed ID: 22299445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of recombinant antigens for diagnosis of melioidosis.
    Allwood EM; Logue CA; Hafner GJ; Ketheesan N; Norton RE; Peak IR; Beacham IR
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):144-53. PubMed ID: 18657105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.
    Swetha RG; Sandhya M; Ramaiah S; Anbarasu A
    J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.
    Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS
    Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melioidosis: where do we stand in the development of an effective vaccine?
    Muruato LA; Torres AG
    Future Microbiol; 2016; 11(4):477-80. PubMed ID: 27081770
    [No Abstract]   [Full Text] [Related]  

  • 20. Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.
    Scott AE; Burtnick MN; Stokes MG; Whelan AO; Williamson ED; Atkins TP; Prior JL; Brett PJ
    Infect Immun; 2014 Aug; 82(8):3206-13. PubMed ID: 24866807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.